Elisidepsin

Star0

DB19522ExperimentalSmall molecule

Elisidepsin is a small molecule drug. Elisidepsin has a monoisotopic molecular weight of 1476.93 Da.

Formula / weight: C₇₅H₁₂₄N₁₄O₁₆ · 1477.899 g/mol (avg)

Resolves to

Compound

UNII0FWR494EC9CAS681272-30-0

Structure

InChIKeyZNVCPJPCKSJWDH-IPZJCCDYSA-NSMILES

[H][C@](NC(=O)[C@H](NC(=O)CC[C@@H](C)CC)C(C)C)([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@]1([H])C(=O)N[C@@H](CCCN)C(=O)N[C@]([H])([C@@H](C)CC)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@]([H])(NC1=O)[C@@H](C)CC)C(C)C)=C\C)C(C)C

Targets

P21860ERBB3

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Elisidepsin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account